Search Results - "Rangel Rivera, Guillermo O."
-
1
Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines
Published in Frontiers in immunology (20-02-2019)“…Adoptive T cell transfer therapy (ACT) using tumor infiltrating lymphocytes or lymphocytes redirected with antigen receptors (CAR or TCR) has revolutionized…”
Get full text
Journal Article -
2
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma
Published in Cell reports (Cambridge) (26-01-2016)“…Ewing sarcoma cells depend on the EWS-FLI1 fusion transcription factor for cell survival. Using an assay of EWS-FLI1 activity and genome-wide RNAi screening,…”
Get full text
Journal Article -
3
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity
Published in Journal for immunotherapy of cancer (01-01-2022)“…BackgroundAdoptive T cell transfer (ACT) therapy improves outcomes in patients with advanced malignancies, yet many individuals relapse due to the infusion of…”
Get full text
Journal Article -
4
Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Published in Frontiers in immunology (18-03-2021)“…Emerging reports show that metabolic pathways can be targeted to enhance T cell-mediated immunity to tumors. Yet, tumors consume key metabolites in the host to…”
Get full text
Journal Article -
5
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells
Published in European journal of immunology (01-09-2020)“…Adoptive T cell transfer therapy induces objective responses in patients with advanced malignancies. Despite these results, some individuals do not respond due…”
Get full text
Journal Article -
6
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity
Published in Cancer research (Chicago, Ill.) (02-01-2024)“…Generating stem-like memory T cells (TSCM) is a potential strategy to improve adoptive immunotherapy. Elucidating optimal ways to modulate signaling pathways…”
Get full text
Journal Article -
7
Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma
Published in Cancer epidemiology, biomarkers & prevention (01-10-2018)“…Remarkable discrepancy exists in outcomes between men and women for multiple malignancies. We sought to expose sex differences in using platelet count and…”
Get full text
Journal Article -
8
IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors
Published in Cancer research (Chicago, Ill.) (15-09-2020)“…The accessibility of adoptive T-cell transfer therapies (ACT) is hindered by the cost and time required for product development. Here we describe a streamlined…”
Get full text
Journal Article -
9
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cells
Published in Molecular therapy (05-07-2023)“…IL-17-producing antigen-specific human T cells elicit potent antitumor activity in mice. Yet, refinement of this approach is needed to position it for clinical…”
Get full text
Journal Article -
10
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Published in Journal for immunotherapy of cancer (30-06-2024)“…BackgroundHow distinct methods of host preconditioning impact the efficacy of adoptively transferred antitumor T helper cells is unknown.MethodsCD4+ T cells…”
Get full text
Journal Article -
11
Modeling ex vivo tumor-infiltrating lymphocyte expansion from established solid malignancies
Published in Oncoimmunology (01-01-2021)“…Adoptive transfer of tumor-infiltrating lymphocytes (TIL) elicits the regression of metastatic malignancies, yet a low proportion of patients achieve complete…”
Get full text
Journal Article -
12
Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer
Published in Cancer research (Chicago, Ill.) (02-12-2022)“…Protein synthesis supports robust immune responses. Nutrient competition and global cell stressors in the tumor microenvironment (TME) may impact protein…”
Get full text
Journal Article -
13
Abstract 2008: Ewing sarcoma cells harboring a translocation that retains EWSR1 exon 8 require HNRNPH1 to express the in-frame oncogenic fusion transcript EWS-FLI1
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…The primary oncogenic event in ∼85% of Ewing sarcomas is a t(11:22)(q24:q12) translocation. This translocation generates a fusion gene containing the 5’ end of…”
Get full text
Journal Article -
14
1507 The Galectin-9-Tim-3 pathway is a novel checkpoint target for patients with biliary tract cancer
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundWe have discovered that galectin-9 (Gal-9), a carbohydrate-binding protein, is expressed in biliary tract cancer (BTC). Upon binding to the receptor…”
Get full text
Journal Article -
15
353 Adoptively transferred Th17 cells engage host B cells for durable tumor destruction
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundAdoptive T cell transfer (ACT) therapy elicits robust immunity in some patients with aggressive malignancies. However, many individuals do not…”
Get full text
Journal Article -
16
Inhibition of PI3Kδ improves tumor specific T cell immunity and metabolic fitness
Published in The Journal of immunology (1950) (01-05-2020)“…Durable responses have been observed with adoptive T cell therapy (ACT) in some patients. However, current protocols used to expand T cells often exhibit…”
Get full text
Journal Article -
17
CD26 enzymatic activity modulates efficient migration of adoptively transferred cancer-specific T cells to solid tumors
Published in The Journal of immunology (1950) (01-05-2020)“…The restricted ability of adoptively transferred T cells to eradicate solid tumors limits their use in some patients. Efforts to improve ACT for solid tumors…”
Get full text
Journal Article -
18
T cells exhibit prolonged immunity against melanoma tumors expressing high, but not low affinity antigens
Published in The Journal of immunology (1950) (01-05-2020)“…We seek to identify the intrinsic properties in T cells from patients responsive or not to immunotherapy. Therapeutic efficacy is seen in patients where the…”
Get full text
Journal Article -
19
IL-6 fuels durable memory for Th17 cell-mediated responses to tumors
Published in Cancer research (Chicago, Ill.) (19-06-2020)“…The accessibility of adoptive T cell transfer therapies (ACT) is hindered by cost and time required for product development. Here we describe a streamlined ACT…”
Get full text
Journal Article -
20
Abstract IA04: Targeting the expression of EWS-FLI1
Published in Clinical cancer research (15-01-2018)“…Post-translational modifications (PTMs) of transcription factors represent potential therapeutic targets for a variety of diseases, including cancer. In the…”
Get full text
Journal Article